Related Experiment Video

Updated: Mar 15, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K

Transient receptor potential cation 3 channel regulates melanoma proliferation and migration

Kayoko Oda1,2, Masanari Umemura3, Rina Nakakaji1

  • 1Cardiovascular Research Institute, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.

The Journal of Physiological Sciences : JPS
|September 11, 2016
PubMed

Insights

Targeting Transient receptor potential, canonical 3 (TRPC3) shows promise for melanoma treatment. Inhibiting TRPC3 with Pyr3 reduced melanoma cell growth and migration in preclinical models, suggesting TRPC3 as a novel therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Melanoma is aggressive and metastatic, with limited treatment options for BRAF wild-type cases.
  • There is a critical need for novel therapeutic targets beyond BRAF mutations.

Purpose of the Study:

  • To investigate the role of Transient receptor potential, canonical 3 (TRPC3) in melanoma.
  • To evaluate TRPC3 as a potential therapeutic target for melanoma treatment.

Main Methods:

  • Assessed TRPC3 expression in human melanoma tissues.
  • Utilized pharmacological inhibition (Pyr3) and genetic silencing (shRNA) of TRPC3.
  • Examined effects on melanoma cell proliferation, migration, and downstream signaling pathways (STAT5, Akt).
  • Evaluated Pyr3 efficacy in a murine melanoma xenograft model.

Main Results:

  • TRPC3 is widely expressed in human melanoma.
  • Pharmacological inhibition and genetic silencing of TRPC3 significantly reduced melanoma cell proliferation and migration.
  • Pyr3 treatment led to dephosphorylation of STAT5 and Akt.
  • In vivo administration of Pyr3 inhibited melanoma tumor growth in mice.

Conclusions:

  • TRPC3 plays a crucial role in melanoma progression.
  • TRPC3 represents a promising novel therapeutic target for melanoma treatment.
Keywords:
MelanomaMetastasisMigrationProliferationPyr3TRPC3

More Related Videos

Expression and Purification of the Human Lipid-sensitive Cation Channel TRPC3 for Structural Determination by Single-particle Cryo-electron Microscopy08:27

Expression and Purification of the Human Lipid-sensitive Cation Channel TRPC3 for Structural Determination by Single-particle Cryo-electron Microscopy

Published on: January 7, 2019

10.0K
A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.7K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K